Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 Gowling WLG (Canada) LLP (6)
Patent
01 2255951 (6)
Product
01 DEFERASIROX (3)
02 Deferasirox (3)
Dosage
01 Dispersible Tablet for Oral Suspension (1)
02 Dispersible Tablets for Oral Suspension (2)
03 TABLET (3)
Exp Date
01 2017-06-24 (6)